查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547061

干眼症治疗设备市场：2024-2031年全球产业分析、规模、占有率、成长、趋势、预测

Dry Eye Disease Treatment Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 160 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份关于全球干眼症（DED）治疗设备市场的综合报告。本报告对关键市场动态进行了深入分析，包括驱动因素、趋势、机会和挑战，并对市场结构提供了深入的见解。

关键见解

  • 干眼症治疗设备市场规模（2024年）：2.123亿美元
  • 预测市场规模（2031年）：3.451亿美元
  • 全球市场成长率（2024-2031年年复合成长率）：6.2%

干眼症治疗设备市场 - 研究范围：

干眼症治疗设备对于控制干眼症的症状非常重要，干眼症的特征是泪液分泌不足和泪液品质差。这些设备包括多种技术，例如穿刺塞、热脉动系统和强烈脉衝光（IPL）设备，目的是缓解症状、改善泪液生成并提高患者舒适度。市场为各种环境中不同严重程度和类型的干眼症提供解决方案，包括眼科诊所、医院和家庭护理环境。

推动市场成长的因素：

全球干眼症治疗设备市场由几个关键因素推动。由于萤幕时间增加、环境因素和人口老化，干眼症的盛行率不断上升，是主要的成长动力。治疗技术的进步，包括改进的穿刺塞设计以及先进的热脉动和 IPL 设备的开发，有助于提高治疗效果和患者满意度。此外，人们对干眼症的认识不断提高，以及更先进、对患者友善的治疗方案的出现，也推动了市场的扩张。

市场限制因素：

儘管干眼症治疗设备市场成长前景广阔，但仍面临挑战。高昂的治疗费用和有限的保险范围可能会限制患者的治疗和采用率，尤其是在医疗保健预算有限的新兴国家。监管障碍和新技术临床验证的需求也可能影响市场成长。解决这些问题需要製造商、医疗保健提供者和政策制定者共同努力，以提高干眼治疗解决方案的可用性和可负担性。

市场机会：

由于技术进步和不断发展的医疗保健实践，干眼症治疗设备市场提供了庞大的商机。数位医疗技术的集成，例如用于症状追踪和远距医疗咨询的行动应用程序，可以增强患者的参与度和对治疗方案的遵守。此外，将治疗设备的使用扩展到传统应用之外，例如治疗干眼症和相关疾病的严重病例，为市场成长开闢了新的途径。策略合作伙伴关係、持续的研发以及设备设计和功能的创新对于利用这些机会并保持市场竞争力非常重要。

本报告解决的关键问题

  • 推动全球干眼治疗设备市场成长的关键因素是什么？
  • 各种医疗机构采用哪些类型的设备和治疗方法？
  • 技术进步如何改变干眼症治疗设备市场的竞争格局？
  • 谁是干眼症治疗设备市场的主要参与者？
  • 全球干眼症治疗器材市场的新趋势与未来前景如何？

目录

第1章 执行摘要

第2章 市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 课题
    • 主要趋势
  • 宏观经济因素
    • 全球 GDP 成长前景
    • 全球医疗保健产业概览
  • 预测因子 - 相关性和影响

第3章 增值见解

  • 产品类型生命週期分析
  • 疾病流行病学
  • 干眼症治疗设备市场：价值链
  • 母市场分析
  • 新冠肺炎（COVID-19）影响评估
  • PESTLE分析
  • 波特五力分析
  • 监管与科技环境

第4章 全球干眼症治疗设备市场展望：实绩（2019-2023年）与预测（2024-2031年）

  • 主要亮点
    • 市场数量（单位）预测
    • 市场规模及年成长率
    • 绝对数量的机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2019-2023年
    • 目前市场规模预测（2023-2031年）
  • 全球干眼症治疗设备市场展望：产品类型
    • 简介/主要发现
    • 2019-2023年历史市场规模（百万美元）和数量（单位）分析，依产品类型
    • 2024-2031年当前市场规模（百万美元）和数量（单位）预测，依产品类型
  • 市场吸引力分析：产品类型
  • 全球干眼症治疗设备市场展望：原因
    • 简介/主要发现
    • 2019-2023年历史市场规模（百万美元）分析：依原因
    • 2024-2031年当前市场规模（百万美元）预测：依原因
  • 市场吸引力分析：原因
  • 全球干眼症治疗设备市场前景：应用
    • 简介/主要发现
    • 2019-2023年历史市场规模（百万美元）分析：依应用
    • 2024-2031年当前市场规模（百万美元）预测：依应用
  • 市场吸引力分析：应用
  • 全球干眼症治疗设备市场展望：最终用途
    • 简介/主要发现
    • 2019-2023年历史市场规模（百万美元）分析：依最终用途
    • 2024-2031年当前市场规模（百万美元）预测：依最终用途
  • 市场吸引力分析：最终用途

第5章 全球干眼症治疗设备市场展望：地区

  • 主要亮点
  • 2019-2023年过往市场规模（百万美元）和数量（单位）分析，依地区
  • 2024-2031年当前市场规模（百万美元）和数量（单位）预测，依地区
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东、非洲
  • 市场吸引力分析：地区

第6章 北美干眼症治疗设备市场展望：实绩（2019-2023）与预测（2024-2031）

第7章 欧洲干眼症治疗设备市场展望：实绩（2019-2023年）与预测（2024-2031年）

第8章 东亚干眼症治疗设备市场展望：实绩（2019-2023年）与预测（2024-2031年）

第9章 南亚/大洋洲干眼症治疗设备市场展望：实绩（2019-2023）与预测（2024-2031）

第10章 拉丁美洲干眼症治疗设备市场展望：实绩（2019-2023年）与预测（2024-2031年）

第11章 中东与非洲干眼症治疗设备市场展望：实绩（2019-2023年）与预测（2024-2031年）

第12章 竞争态势

  • 2023年市占率分析
  • 市场结构
    • 竞争强度图：依市场划分
    • 竞争仪表板
    • 表观产能
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Johnson and Johnson Services Inc.
    • AbbVie Inc.
    • Lumenis Be Ltd
    • ESW-Vision
    • Mibo Medical Group
    • Sight Sciences.
    • Eyedetect Medical Inc.
    • BlephEx
    • NuSight Medicals-Nulids LLC
    • 其他

第13章 附录

  • 调查方法
  • 调查的先决条件
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP34725

Persistence Market Research has recently released a comprehensive report on the global market for dry eye disease (DED) treatment devices. This report provides an in-depth analysis of crucial market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

  • Dry Eye Disease Treatment Devices Market Size (2024E): US$212.3 Mn
  • Projected Market Value (2031F): US$345.1 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.2%

Dry Eye Disease Treatment Devices Market - Report Scope:

Dry eye disease treatment devices are integral to managing symptoms of dry eye disease, a condition characterized by inadequate tear production or poor tear quality. These devices include a range of technologies such as punctal plugs, thermal pulsation systems, and intense pulsed light (IPL) devices, which aim to alleviate symptoms, improve tear production, and enhance patient comfort. The market serves various settings including ophthalmology clinics, hospitals, and homecare environments, offering solutions that cater to different severities and types of dry eye disease.

Market Growth Drivers:

The global dry eye disease treatment devices market is driven by several key factors. Increasing prevalence of dry eye disease, spurred by rising screen time, environmental factors, and aging populations, is a significant growth driver. Advances in treatment technology, including improved punctal plug designs and the development of sophisticated thermal pulsation and IPL devices, contribute to enhanced treatment efficacy and patient satisfaction. Additionally, growing awareness about dry eye disease and the availability of more advanced and patient-friendly treatment options further fuel market expansion.

Market Restraints:

Despite promising growth prospects, the dry eye disease treatment devices market faces challenges. High treatment costs and limited insurance coverage can restrict patient access and adoption rates, particularly in emerging economies with constrained healthcare budgets. Regulatory hurdles and the need for clinical validation of new technologies can also impact market growth. Addressing these issues requires collaboration between manufacturers, healthcare providers, and policymakers to improve accessibility and affordability of dry eye disease treatment solutions.

Market Opportunities:

The dry eye disease treatment devices market presents significant opportunities driven by technological advancements and evolving healthcare practices. The integration of digital health technologies, such as mobile apps for symptom tracking and telemedicine consultations, enhances patient engagement and adherence to treatment protocols. Moreover, expanding applications of treatment devices beyond traditional uses, such as for managing severe cases of dry eye disease and associated conditions, open new avenues for market growth. Strategic partnerships, ongoing R&D, and innovation in device design and functionality are crucial to capitalizing on these opportunities and maintaining a competitive edge in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the dry eye disease treatment devices market globally?
  • Which types of devices and treatment methods are leading adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the dry eye disease treatment devices market?
  • Who are the key players contributing to the dry eye disease treatment devices market, and what strategies are they employing to stay relevant?
  • What are the emerging trends and future prospects in the global dry eye disease treatment devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global dry eye disease treatment devices market, including Allergan plc, Johnson & Johnson Vision, and TearLab Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced treatment devices, such as next-generation thermal pulsation systems and enhanced punctal plugs. Collaborations with healthcare providers and investment in marketing and education programs foster market growth and improve patient outcomes. Additionally, emphasis on clinical research and evidence-based practices supports market expansion and drives innovation in the dry eye disease treatment landscape.

Key Companies Profiled:

  • Allergan plc
  • Johnson & Johnson Vision
  • TearLab Corporation
  • Alcon Laboratories, Inc.
  • Ocular Therapeutix, Inc.
  • EyeGate Pharmaceuticals, Inc.
  • Shire Pharmaceuticals
  • Novartis AG
  • Bausch & Lomb Incorporated
  • Ciba Vision Corporation

Dry Eye Disease Treatment Devices Market Segmentation

By Product Type

  • Meibomian Gland Unclogging Devices
  • Wearable Devices
  • Punctual Occlusion Devices
  • Pain Relieving Devices

By Cause

  • Idiopathic
  • Rare Disease
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Chronic Dry Eye
  • Acute Dry Eye

By End User

  • Hospitals and Clinics
  • Home Care

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Growth Outlook
    • 2.3.2. Global Healthcare Industry Overview
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Lifecycle Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Dry Eye Disease Treatment Devices Market: Value Chain
  • 3.4. Parent Market Analysis
  • 3.5. Covid-19 Impact Assessment
  • 3.6. PESTLE Analysis
  • 3.7. Porter Five Force's Analysis
  • 3.8. Regulatory and Technology Landscape

4. Global Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Volume (Units) Projections
    • 4.1.2. Market Size and Y-o-Y Growth
    • 4.1.3. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size Analysis, 2019-2023
    • 4.2.2. Current Market Size Forecast, 2023-2031
  • 4.3. Global Dry Eye Disease Treatment Devices Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019-2023
    • 4.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
      • 4.3.3.1. Meibomian Gland Unclogging Devices
      • 4.3.3.2. Wearable Devices
      • 4.3.3.3. Punctual Occlusion Devices
      • 4.3.3.4. Pain Relieving Devices
      • 4.3.3.5. Others
  • 4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Dry Eye Disease Treatment Devices Market Outlook: Cause
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Mn) Analysis By Cause, 2019-2023
    • 4.5.3. Current Market Size (US$ Mn Forecast By Cause, 2024-2031
      • 4.5.3.1. Idiopathic
      • 4.5.3.2. Rare Disease
      • 4.5.3.3. Surgery
      • 4.5.3.4. Drug Intake Associated
      • 4.5.3.5. Digital Exposure
      • 4.5.3.6. Age-Related
  • 4.6. Market Attractiveness Analysis: Cause
  • 4.7. Global Dry Eye Disease Treatment Devices Market Outlook: Application
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
    • 4.7.3. Current Market Size (US$ Mn Forecast By Application, 2024-2031
      • 4.7.3.1. Chronic Dry Eye
      • 4.7.3.2. Acute Dry Eye
  • 4.8. Market Attractiveness Analysis: Application
  • 4.9. Global Dry Eye Disease Treatment Devices Market Outlook: End Use
    • 4.9.1. Introduction / Key Findings
    • 4.9.2. Historical Market Size (US$ Mn) Analysis By End Use, 2019-2023
    • 4.9.3. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
      • 4.9.3.1. Hospitals and Clinics
      • 4.9.3.2. Home Care
  • 4.10. Market Attractiveness Analysis: End Use

5. Global Dry Eye Disease Treatment Devices Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019-2023
  • 5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Cause
    • 6.3.4. By Application
    • 6.3.5. By End Use
  • 6.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 6.4.1. U.S.
    • 6.4.2. Canada
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Meibomian Gland Unclogging Devices
    • 6.5.2. Wearable Devices
    • 6.5.3. Punctual Occlusion Devices
    • 6.5.4. Pain Relieving Devices
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 6.6.1. Idiopathic
    • 6.6.2. Rare Disease
    • 6.6.3. Surgery
    • 6.6.4. Drug Intake Associated
    • 6.6.5. Digital Exposure
    • 6.6.6. Age-Related
  • 6.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 6.7.1. Chronic Dry Eye
    • 6.7.2. Acute Dry Eye
  • 6.8. Market Attractiveness Analysis
  • 6.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 6.9.1. Hospitals and Clinics
    • 6.9.2. Home Care
  • 6.10. Market Attractiveness Analysis

7. Europe Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Cause
    • 7.3.4. By Application
    • 7.3.5. By End Use
  • 7.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. U.K.
    • 7.4.4. Italy
    • 7.4.5. Spain
    • 7.4.6. Russia
    • 7.4.7. Turkey
    • 7.4.8. Rest of Europe
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Meibomian Gland Unclogging Devices
    • 7.5.2. Wearable Devices
    • 7.5.3. Punctual Occlusion Devices
    • 7.5.4. Pain Relieving Devices
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 7.6.1. Idiopathic
    • 7.6.2. Rare Disease
    • 7.6.3. Surgery
    • 7.6.4. Drug Intake Associated
    • 7.6.5. Digital Exposure
    • 7.6.6. Age-Related
  • 7.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 7.7.1. Chronic Dry Eye
    • 7.7.2. Acute Dry Eye
  • 7.8. Market Attractiveness Analysis
  • 7.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 7.9.1. Hospitals and Clinics
    • 7.9.2. Home Care
  • 7.10. Market Attractiveness Analysis

8. East Asia Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Cause
    • 8.3.4. By Application
    • 8.3.5. By End Use
  • 8.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. South Korea
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Meibomian Gland Unclogging Devices
    • 8.5.2. Wearable Devices
    • 8.5.3. Punctual Occlusion Devices
    • 8.5.4. Pain Relieving Devices
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 8.6.1. Idiopathic
    • 8.6.2. Rare Disease
    • 8.6.3. Surgery
    • 8.6.4. Drug Intake Associated
    • 8.6.5. Digital Exposure
    • 8.6.6. Age-Related
  • 8.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 8.7.1. Chronic Dry Eye
    • 8.7.2. Acute Dry Eye
  • 8.8. Market Attractiveness Analysis
  • 8.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 8.9.1. Hospitals and Clinics
    • 8.9.2. Home Care
  • 8.10. Market Attractiveness Analysis

9. South Asia & Oceania Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Cause
    • 9.3.4. By Application
    • 9.3.5. By End Use
  • 9.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 9.4.1. India
    • 9.4.2. Southeast Asia
    • 9.4.3. ANZ
    • 9.4.4. Rest of South Asia & Oceania
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 9.5.1. Meibomian Gland Unclogging Devices
    • 9.5.2. Wearable Devices
    • 9.5.3. Punctual Occlusion Devices
    • 9.5.4. Pain Relieving Devices
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 9.6.1. Idiopathic
    • 9.6.2. Rare Disease
    • 9.6.3. Surgery
    • 9.6.4. Drug Intake Associated
    • 9.6.5. Digital Exposure
    • 9.6.6. Age-Related
  • 9.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 9.7.1. Chronic Dry Eye
    • 9.7.2. Acute Dry Eye
  • 9.8. Market Attractiveness Analysis
  • 9.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 9.9.1. Hospitals and Clinics
    • 9.9.2. Home Care
  • 9.10. Market Attractiveness Analysis

10. Latin America Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Cause
    • 10.3.4. By Application
    • 10.3.5. By End Use
  • 10.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 10.4.1. Brazil
    • 10.4.2. Mexico
    • 10.4.3. Rest of Latin America
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 10.5.1. Meibomian Gland Unclogging Devices
    • 10.5.2. Wearable Devices
    • 10.5.3. Punctual Occlusion Devices
    • 10.5.4. Pain Relieving Devices
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 10.6.1. Idiopathic
    • 10.6.2. Rare Disease
    • 10.6.3. Surgery
    • 10.6.4. Drug Intake Associated
    • 10.6.5. Digital Exposure
    • 10.6.6. Age-Related
  • 10.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 10.7.1. Chronic Dry Eye
    • 10.7.2. Acute Dry Eye
  • 10.8. Market Attractiveness Analysis
  • 10.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 10.9.1. Hospitals and Clinics
    • 10.9.2. Home Care
  • 10.10. Market Attractiveness Analysis

11. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019-2023
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Cause
    • 11.3.4. By Application
    • 11.3.5. By End Use
  • 11.4. Current Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 11.4.1. GCC
    • 11.4.2. Egypt
    • 11.4.3. South Africa
    • 11.4.4. Northern Africa
    • 11.4.5. Rest of Middle East & Africa
  • 11.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 11.5.1. Meibomian Gland Unclogging Devices
    • 11.5.2. Wearable Devices
    • 11.5.3. Punctual Occlusion Devices
    • 11.5.4. Pain Relieving Devices
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Mn) Forecast By Cause, 2024-2031
    • 11.6.1. Idiopathic
    • 11.6.2. Rare Disease
    • 11.6.3. Surgery
    • 11.6.4. Drug Intake Associated
    • 11.6.5. Digital Exposure
    • 11.6.6. Age-Related
  • 11.7. Current Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 11.7.1. Chronic Dry Eye
    • 11.7.2. Acute Dry Eye
  • 11.8. Market Attractiveness Analysis
  • 11.9. Current Market Size (US$ Mn) Forecast By End Use, 2024-2031
    • 11.9.1. Hospitals and Clinics
    • 11.9.2. Home Care
  • 11.10. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
    • 12.2.3. Apparent Production Capacity
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Johnson and Johnson Services Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. AbbVie Inc.
    • 12.3.3. Lumenis Be Ltd
    • 12.3.4. ESW-Vision
    • 12.3.5. Mibo Medical Group
    • 12.3.6. Sight Sciences.
    • 12.3.7. Eyedetect Medical Inc.
    • 12.3.8. BlephEx
    • 12.3.9. NuSight Medicals-Nulids LLC
    • 12.3.10. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations